EUDA Health Faces 'Substantial Doubt' on Going Concern Amid $50.1M Deficit

TL;DR

**EUDA Health is on life support with a $50.1M deficit, making it a high-risk bet for traders.**

AI Summary

EUDA Health Holdings Ltd (EUDAW) filed an Amendment No. 1 to its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, primarily to amend and restate page F-1. The company reported an accumulated deficit of $50,100,426 and a deficit in shareholders' equity of $2,553,059 as of December 31, 2024. These significant financial challenges raise substantial doubt about the company's ability to continue as a going concern, as highlighted by its independent registered public accounting firm, J&S Associate PLT. The audit opinion, issued on April 29, 2025, confirmed the fair presentation of the 2024 financial statements in conformity with U.S. GAAP, but explicitly noted the going concern uncertainty. The amendment also retrospectively reflects the adoption of Accounting Standards Update relating to segment reporting (ASC 280) for the 2023 financial statements. Alfred Lim, CEO, signed the amendment on September 11, 2025.

Why It Matters

This amendment, while seemingly minor, carries significant weight for investors, employees, and customers due to the explicit 'going concern' warning. The accumulated deficit of $50,100,426 and a $2,553,059 shareholder equity deficit signal deep financial distress, potentially impacting EUDA Health's ability to fund operations, retain talent, or fulfill customer commitments. In the competitive digital health sector, such financial instability could erode market confidence and make it challenging to compete with better-capitalized rivals, ultimately affecting the company's long-term viability and shareholder value.

Risk Assessment

Risk Level: high — The risk level is high due to the explicit 'Substantial Doubt about the Company's Ability to Continue as a Going Concern' stated by the independent auditor. This is evidenced by an accumulated deficit of $50,100,426 and a deficit in shareholders' equity of $2,553,059 as of December 31, 2024. These figures indicate severe financial instability.

Analyst Insight

Investors should exercise extreme caution and consider liquidating positions in EUDAW given the explicit going concern warning and significant accumulated deficit. New investors should avoid this stock until management presents a clear, funded plan to address its financial instability and the auditor removes the going concern qualification.

Key Numbers

• $50.1M — Accumulated Deficit (As of December 31, 2024, indicating significant historical losses.)
• $2.55M — Shareholders' Equity Deficit (As of December 31, 2024, highlighting negative equity.)
• 37,153,049 — Ordinary Shares Outstanding (As of December 31, 2024, providing context for per-share metrics.)
• 2024 — Fiscal Year End (The period for which the financial statements were audited.)

Key Players & Entities

• EUDA Health Holdings Limited (company) — Registrant and subject of the 20-F/A filing
• Alfred Lim (person) — Chief Executive Officer of EUDA Health Holdings Limited
• J&S Associate PLT (company) — Independent Registered Public Accounting Firm for EUDA Health Holdings Limited
• SEC (regulator) — U.S. Securities and Exchange Commission
• $50,100,426 (dollar_amount) — Accumulated deficit as of December 31, 2024
• $2,553,059 (dollar_amount) — Deficit in shareholders' equity as of December 31, 2024
• December 31, 2024 (date) — Fiscal year end covered by the annual report
• April 29, 2025 (date) — Date of the Original Filing and auditor's report
• September 11, 2025 (date) — Date of filing for Amendment No. 1
• ASC 280 (regulation) — Accounting Standards Update relating to segment reporting

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: The company has an accumulated deficit of $50,100,426 and a deficit in shareholders' equity of $2,553,059 as of December 31, 2024. This raises substantial doubt about the company's ability to continue as a going concern, as noted by the independent registered public accounting firm.

Industry Context

EUDA Health Holdings Ltd operates within the healthcare sector, which is characterized by rapid technological advancements, evolving regulatory landscapes, and intense competition. Companies in this space often focus on innovation in diagnostics, treatment, and digital health solutions to gain market share. The industry is also subject to significant investment and consolidation, with a constant drive for efficiency and improved patient outcomes.

Regulatory Implications

As a publicly traded company in the U.S., EUDA Health Holdings Ltd is subject to SEC regulations and U.S. GAAP. The filing of a Form 20-F/A highlights the importance of accurate and timely financial reporting. The going concern warning from auditors necessitates careful monitoring by regulators and investors regarding the company's financial stability and future viability.

What Investors Should Do

1. Review Management's Plans
2. Monitor Cash Burn and Funding
3. Assess Segment Performance (Post-ASC 280 Adoption)

Key Dates

• 2024-12-31: Fiscal Year End — The period for which the financial statements were audited, revealing significant financial challenges.
• 2025-04-29: Audit Opinion Issued — Independent auditors J&S Associate PLT issued their opinion on the 2024 financial statements, confirming fair presentation but highlighting going concern uncertainty.
• 2025-09-11: Amendment No. 1 Filed — EUDA Health Holdings Ltd filed an amendment to its 20-F report, primarily to restate page F-1, signed by CEO Alfred Lim.

Glossary

Form 20-F/A

An amendment to an annual report filed by foreign private issuers with the U.S. Securities and Exchange Commission (SEC). It is used to correct or supplement information previously filed. (This filing is an amendment to EUDA Health Holdings Ltd's annual report, indicating a correction or update to previously submitted financial information.)

Accumulated Deficit

The total cumulative net losses of a company that have not been offset by profits or additional paid-in capital. It represents a negative retained earnings balance. (EUDA Health Holdings Ltd has a significant accumulated deficit of $50,100,426 as of December 31, 2024, indicating substantial historical losses.)

Shareholders' Equity Deficit

A situation where a company's liabilities exceed its assets, resulting in a negative net worth. This means the company owes more than it owns. (EUDA Health Holdings Ltd has a deficit in shareholders' equity of $2,553,059 as of December 31, 2024, indicating negative net worth.)

Going Concern

An assumption that a company will continue to operate for the foreseeable future, typically at least 12 months from the reporting date. If there is substantial doubt, it must be disclosed. (The company's financial condition, including its accumulated deficit and equity deficit, raises substantial doubt about its ability to continue as a going concern.)

ASC 280

Accounting Standards Codification Topic 280, which provides guidance on segment reporting. It requires companies to report information about their operating segments, products and services, geographic areas, and major customers. (EUDA Health Holdings Ltd retrospectively adopted ASC 280 for its 2023 financial statements, impacting how its business segments are reported.)

Year-Over-Year Comparison

This filing is an Amendment No. 1 to the 2024 Form 20-F, primarily to restate page F-1. It does not provide comparative figures for revenue, margins, or other key financial metrics against the prior year (2023) within the amendment itself. However, the amendment does note the retrospective adoption of ASC 280 for the 2023 financial statements, which may impact comparability of segment data if previously disclosed.

Key Financial Figures

• $50,100,426 — suffered from an accumulated deficit of $50,100,426 as of December 31, 2024 and a deficit i
• $2,553,059 — nd a deficit in shareholders' equity of $2,553,059 as of that date. These matters raise su

Filing Documents

• form20-fa.htm (20-F/A) — 76KB
• form20-fa_001.jpg (GRAPHIC) — 2KB
• 0001493152-25-013081.txt ( ) — 359KB
• euda-20241231.xsd (EX-101.SCH) — 4KB
• euda-20241231_def.xml (EX-101.DEF) — 30KB
• euda-20241231_lab.xml (EX-101.LAB) — 41KB
• euda-20241231_pre.xml (EX-101.PRE) — 29KB
• form20-fa_htm.xml (XML) — 13KB

SIGNATURES

SIGNATURES The registrant hereby certifies that it meets all of the requirements for filing its annual report on Form 20-F/A and that it has duly caused and authorized the undersigned to sign this annual report on its behalf. EUDA Health Holdings Limited By: /s/ Alfred Lim Name: Alfred Lim Title: Chief Executive Officer Date: September 11, 2025 3

View Full Filing

View this 20-F/A filing on SEC EDGAR